XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 13.0 $ 13.2
Accounts receivable—trade, net of allowance for doubtful accounts of $8.2 and $7.5, respectively 75.2 74.6
Accounts receivable—other 6.3 9.2
Prepaid expenses and other 20.6 15.4
Total current assets 115.1 112.4
Right-of-use assets—operating 25.9  
Plant, property and equipment, net 1,058.5 1,053.4
Franchise operating rights 809.2 809.2
Goodwill 408.8 408.8
Intangible assets subject to amortization, net 3.9 3.6
Other noncurrent assets 37.5 32.2
Total assets 2,458.9 2,419.6
Current liabilities    
Accounts payable—trade 30.7 42.0
Accrued interest 2.7 4.6
Current lease liability—operating 6.0  
Accrued liabilities and other 103.7 93.2
Current portion of debt and finance lease obligations 26.9 24.1
Current portion of unearned service revenue 53.8 60.2
Total current liabilities 223.8 224.1
Long-term debt and finance lease obligations—less current portion and debt issuance costs 2,271.5 2,271.4
Long-term lease liability—operating 21.2  
Deferred income taxes, net 202.3 201.4
Other noncurrent liabilities 20.9 13.0
Total liabilities 2,739.7 2,709.9
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, $0.01 par value, 100,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $0.01 par value, 700,000,000 shares authorized; 92,515,078 and 90,572,693 issued as of June 30, 2019 and December 31, 2018, respectively; 84,473,673 and 82,680,380 outstanding as of June 30, 2019 and December 31, 2018, respectively 0.9 0.9
Additional paid-in capital 317.6 312.7
Accumulated other comprehensive loss (18.1) (6.5)
Accumulated deficit (501.7) (519.3)
Treasury stock at cost, 8,041,405 and 7,892,313 shares as of June 30, 2019 and December 31, 2018, respectively (79.5) (78.1)
Total stockholders’ deficit (280.8) [1] (290.3)
Total liabilities and stockholders’ deficit $ 2,458.9 $ 2,419.6
[1] Included in outstanding shares as of March 31, 2019 and June 30, 2019 are 3,703,649 and 3,601,021, respectively, of non-vested shares of restricted stock awards granted to employees and directors.